Vanishing Bile Duct Syndrome

Ludwig, 1988, Idiopathic adulthood ductopenia, J Hepatol, 7, 193, 10.1016/S0168-8278(88)80482-3 Nakanuma, 2001, Pathology and pathogenesis of intrahepatic bile duct loss, J Hepatobiliary Pancreat Surg, 8, 303, 10.1007/s005340170002 Guebel, 2000, Drug and toxin-induced bile disorders, J Gastroenterol Hepatol, 15, 1232 Moore, 1988 Clotman, 2003, Hepatic artery malformations associated with a primary defect in intrahepatic bile duct development, J Hepatol, 39, 686, 10.1016/S0168-8278(03)00409-4 Holund, 1980, Reproducibility of liver biopsy diagnosis in relation to the size of the specimen, Scand J Gastroenterol, 15, 329, 10.3109/00365528009181479 Ludwig, 1987, The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation, Hepatology, 7, 476, 10.1002/hep.1840070311 Ludwig, 1998, Idiopathic adulthood ductopenia: an update, Mayo Clin Proc, 73, 285, 10.4065/73.3.285 Kahn, 1997, Human ontogeny of the bile duct to portal space ration: clinical and laboratory findings in 10 cases, J Pediatr Gastroenterol Nutr, 24, 44, 10.1097/00005176-199701000-00011 Alagille, 1987, Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): review of 80 cases, J Pediatr, 110, 195, 10.1016/S0022-3476(87)80153-1 Li, 1997, Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1, Nat Genet, 16, 243, 10.1038/ng0797-243 O'Reilly, 2006, Biliary hypoplasia in Williams syndrome, Arch Dis Child, 91, 420, 10.1136/adc.2005.074740 Woolf, 1993, Disappearing intrahepatic bile ducts: the syndromes and their mechanisms, Semin Liver Dis, 13, 261, 10.1055/s-2007-1007354 Kita, 2002, Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis, J Clin Invest, 109, 1231, 10.1172/JCI0214698 Colucci, 1986, In situ characterization of the cell-surface antigens of the mononuclear cell infiltrate and bile duct epithelium in primary biliary cirrhosis, Clin Immunol Immunopathol, 41, 35, 10.1016/0090-1229(86)90049-8 Lacerda, 1995, Antimitochondrial antibody-negative primary biliary cirrhosis, Am J Gastroenterol, 90, 247 Vierling, 1990, Disappearing bile ducts: immunologic mechanisms, Hosp Pract, 141, 10.1080/21548331.1990.11703976 Wee, 1985, Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts?, Ann Intern Med, 102, 581, 10.7326/0003-4819-102-5-581 Ludwig, 1991, Small-duct primary sclerosing cholangitis, Semin Liver Dis, 11, 11, 10.1055/s-2008-1040417 Murphy, 1990, Small bile duct abnormalities in sarcoidosis, J Clin Gastroenterol, 12, 555, 10.1097/00004836-199010000-00014 Agostini, 2000, New pathogenetic insights into the sarcoid granuloma, Curr Opin Rheumatol, 12, 71, 10.1097/00002281-200001000-00012 Thompson, 1984, Sclerosing cholangitis and histiocytosis X, Gut, 25, 526, 10.1136/gut.25.5.526 Sherlock, 1987, The syndrome of disappearing intrahepatic bile ducts, Lancet, 493, 10.1016/S0140-6736(87)91802-2 Liangpunsakul, 2002, Hodgkin's diseases presenting as cholestatic hepatitis with prominent ductal injury, Eur J Gastroenterol Hepatol, 14, 323, 10.1097/00042737-200203000-00019 Ozkan, 2001, The vanishing bile duct syndrome in a child with Hodgkin disease, Med Pediatr Oncol, 36, 398, 10.1002/mpo.1096 Hubscher, 1993, Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma, Hepatology, 17, 70, 10.1002/hep.1840170114 Dich, 1989, Hepatic involvement in Hodgkin's disease, Cancer, 64, 2121, 10.1002/1097-0142(19891115)64:10<2121::AID-CNCR2820641025>3.0.CO;2-L Kim, 2000, Variant forms of cholestatic diseases involving small bile ducts in adults, Am J Gastroenterol, 95, 1130, 10.1111/j.1572-0241.2000.01999.x Lefkowitch, 1993, Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B, Gastroenterology, 104, 595, 10.1016/0016-5085(93)90432-C Delladetsima, 2001, Cholestatic syndrome with bile duct damage and loss in renal transplant recipients with HCV infection, Liver, 21, 81, 10.1034/j.1600-0676.2001.021002081.x Kikuchi, 2000, Vanishing bile duct syndrome associated with chronic EBV infection, Dig Dis Sci, 45, 160, 10.1023/A:1005434015863 Levy, 2003, Drug-induced cholestasis, Clin Liver Dis, 7, 311, 10.1016/S1089-3261(03)00032-1 Velayudham, 2003, Drug-induced cholestasis, Expert Opin Drug Saf, 2, 287, 10.1517/14740338.2.3.287 Choi, 2005, [A case of vanishing bile duct syndrome associated with hypersensitivity to allopurinol], Korean J Hepatol, 11, 80 Capra, 2005, Vanishing bile duct syndrome and inflammatory pseudotumor associated with a case of anabolic steroid abuse, Dig Dis Sci, 50, 1535, 10.1007/s10620-005-2876-2 Srivastava, 1998, Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child, Gastroenterology, 115, 743, 10.1016/S0016-5085(98)70154-4 Taghian, 2004, Acute vanishing bile duct syndrome after ibuprofen therapy in a child, J Pediatr, 145, 273, 10.1016/j.jpeds.2004.05.027 Hautekeete, 1999, HLA association of amoxicillin-clavulanate-induced hepatitis, Gastroenterology, 117, 1181, 10.1016/S0016-5085(99)70404-X Desmet, 1997, Vanishing bile duct syndrome in drug-induced liver disease, J Hepatol, 26S, 31, 10.1016/S0168-8278(97)82330-6 Burak, 2000, Familial idiopathic adulthood ductopenia: a report of five cases in three generations, J Hepatol, 32, 159, 10.1016/S0168-8278(00)80203-2 Theise, 1999, The canals of Hering and hepatic stem cells in humans, Hepatology, 30, 1425, 10.1002/hep.510300614 Roskams, 2004, Nomenclature of the finer branches of the biliary tree: canals, ductules and ductular reaction in human livers, Hepatology, 39, 1739, 10.1002/hep.20130 Van den Heuven, 2006, Preservation of bile ductules mitigates bile duct loss, Am J Transplant, 6, 2660, 10.1111/j.1600-6143.2006.01511.x Van den Heuvel, 2004, Impaired regeneration of biliary cells in human chronic liver allograft rejection. Special emphasis on the role of the finest branches of the biliary tree, Liver Transpl, 10, 28, 10.1002/lt.20029 Saxena, 2002, Destruction of canals of Hering in primary biliary cirrhosis, Hum Pathol, 33, 983, 10.1053/hupa.2002.128060 Van dn Heuvel, 2006, The finest branches of the biliary tree might induce biliary vascularization necessary for biliary regeneration, J Hepatol, 44, 947, 10.1016/j.jhep.2005.08.011 Moreno, 1997, Idiopathic biliary ductopenia in adults without symptoms of liver disease, N Engl J Med, 336, 835, 10.1056/NEJM199703203361204 Boyer, 2007, New perspectives for the treatment of cholestasis: lessons from basic science applied clinically, J Hepatol, 46, 365, 10.1016/j.jhep.2006.12.001 Hagey, 1993, Ursodeoxycholic acid in the Ursidae: biliary bile acids of bears, pandas, and related carnivores, J Lipid Res, 34, 1911, 10.1016/S0022-2275(20)35109-9 Pusl, 2006, Ursodeoxycholic acid treatment of vanishing bile duct syndromes, World J Gastroenterol, 12, 3487, 10.3748/wjg.v12.i22.3487 Lazaridis, 2001, Ursodeoxycholic acid mechanisms of action and clinical use in hepatobiliary disorders, J Hepatol, 35, 134, 10.1016/S0168-8278(01)00092-7 Smith, 2005, Vanishing bile duct syndrome: amoxicillin-clavulanic acid associated intra-hepatic cholestasis responsive to ursodeoxycholic acid, J Pediatr Gastroenterol Nutr, 41, 469, 10.1097/01.mpg.0000178086.44155.73 O'Brien, 1996, Drug-induced vanishing bile duct syndrome: response to ursodiol, Am J Gastroenterol, 91, 1456